Walleye Capital
HELP icon

Walleye Capital’s Helus Pharma Inc. Common Stock HELP Stock Holding History

Walleye Capital’s Portfolio HELP Stock Details HELP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.32M Buy
+502,554
New +$2.51M 0.01% 1105
2025
Q4 		– Sell
-53,250
Closed -$314K – 4654
2025
Q3 		$314K Buy
+53,250
New +$377K ﹤0.01% 2977

Other funds holding HELP

VR Adviser
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
OrbiMed
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Rosalind Advisors
Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return
Sphera Funds Management
Sphera Funds Management Tel Aviv, Israel $767M AUM 119.71% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $366M AUM 474.6% 1-Year Est. Return
DA
DCF Advisers Greenwich, Connecticut $444M AUM 151.5% 1-Year Est. Return
Sio Capital Management
Sio Capital Management New York $604M AUM 96.57% 1-Year Est. Return
Nan Fung Group Holdings
Nan Fung Group Holdings Kai Tak, Hong Kong $131M AUM 86.64% 1-Year Est. Return

Walleye Capital's HELP Position: Q2 2026 in Review

Walleye Capital opened a new position in Helus Pharma Inc. Common Stock (HELP) in Q2 2026: 502,554 shares worth $3.32M. The stake represents 0.01% of the portfolio and ranks #1105 among its holdings. This is a return to the name: Walleye Capital previously reported a position in HELP as recently as Q3 2025.

Walleye Capital first reported a position in HELP in Q3 2025 and has held it in 2 quarters since. 99 funds tracked by Wall St. Rank hold HELP as of Q2 2026.

  • Walleye Capital held 502,554 shares of Helus Pharma Inc. Common Stock worth $3.32M as of Q2 2026.
  • Helus Pharma Inc. Common Stock was a new Walleye Capital position in Q2 2026.
  • Helus Pharma Inc. Common Stock made up 0.01% of Walleye Capital's portfolio in Q2 2026, its #1105 holding.
  • Walleye Capital first reported a position in Helus Pharma Inc. Common Stock in Q3 2025 and has held it in 2 quarters since.
  • 99 funds tracked by Wall St. Rank held Helus Pharma Inc. Common Stock as of Q2 2026.

Based on Walleye Capital's 13F filing for Q2 2026, filed 3 Aug 2026.